Categories: World

GSK – PRESENTS POSITIVE DATA TO EXPAND JIDEYTRO TO FIRST-LINE ROS1-POSITIVE NSCLC

GSK – PRESENTS POSITIVE DATA TO EXPAND JIDEYTRO TO FIRST-LINE ROS1-POSITIVE NSCLC(The article has been published through a syndicated feed. Except for the headline, the content has been…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: September 14, 2026 05:27:05 IST

GSK – PRESENTS POSITIVE DATA TO EXPAND JIDEYTRO TO FIRST-LINE ROS1-POSITIVE NSCLC

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: September 14, 2026 05:27:05 IST

Recent Posts

Trump says 'very negative forces' raising exaggerated concerns over AI

By Bo Erickson and Padraic Halpin DOONBEG, Ireland, Sept 13 (Reuters) - U.S. President Donald…

September 14, 2026

Ahead of Fed meeting, Trump says US should have world's lowest interest rate

By Bo Erickson, Padraic Halpin and Conor Humphries DOONBEG, Ireland, Sept 13 (Reuters) - No…

September 14, 2026

VAR in focus as Haaland goal gives Man City controversial derby win

VIDEO SHOWS: POST-MATCH PRESS CONFERENCES WITH MANCHESTER UNITED COACH, MICHAEL CARRICK, AND MANCHESTER CITY COACH,…

September 14, 2026